Salta alla navigazione principale
Salta alla ricerca
Salta al contenuto principale
Ordina per
Immunology and Microbiology
P53
100%
DNA Damage
100%
Upregulation
100%
Mismatch DNA Repair
100%
Cytotoxicity
100%
Carcinoma Cell
100%
Cross-Resistance
100%
G1 Phase Cell Cycle Checkpoint
100%
Nucleophilicity
100%
Ovarian Carcinoma Cell Line
100%
G2 Phase Cell Cycle Checkpoint
100%
DNA Damage Checkpoint
100%
Neurofilament
100%
Drug Inactivation
100%
Programmed Cell Death
100%
Glutathione
100%
Metallothionein
100%
Keyphrases
Platinum Complexes
100%
Trinuclear
100%
Resistance Development
100%
Ovarian Carcinoma Cells
100%
BBR3464
100%
Resistant Cells
45%
Cisplatin
36%
P21Cip1
36%
A2780
36%
Checkpoint Kinase 1 (CHK1)
18%
Apoptosis
9%
Metallothionein
9%
Sublethal
9%
Glutathione
9%
Neurofilament
9%
Cytotoxicity
9%
Cisplatin Resistance
9%
PMS2
9%
Drug-induced
9%
Platinum Drugs
9%
DNA Lesions
9%
Cell Resistance
9%
DNA Platination
9%
Cisplatin-induced
9%
Cellular Accumulation
9%
Resistance Level
9%
Cross-resistance
9%
Ovarian Cancer Cells
9%
DNA Mismatch Repair System
9%
MLH1
9%
Reduced Expression
9%
Drug-resistant Tumor
9%
Nucleophilic
9%
Response Pattern
9%
Regulatory Pathways
9%
G1 Arrest
9%
Drug Inactivation
9%
Regulatory Loop
9%
DNA Damage Checkpoint
9%
Reduced Susceptibility
9%
G2-M Arrest
9%
Drug Accessibility
9%
G2 Checkpoint
9%
Medicine and Dentistry
Platinum Complex
100%
Carcinoma Cell
100%
Krukenberg Tumor
100%
Triplatin Tetranitrate
100%
Cisplatin
54%
Neoplasm
9%
Programmed Cell Death
9%
Glutathione
9%
Cytotoxicity
9%
Protein P53
9%
DNA Mismatch Repair
9%
DNA Damage
9%
Upregulation
9%
Cross Resistance
9%
G1/S Transition
9%
Neurofilament
9%
Cell DNA
9%
Drug Inactivation
9%
G2 Phase Cell Cycle Checkpoint
9%
DNA Damage Checkpoint
9%
Ovarian Carcinoma Cell Line
9%
Metallothionein
9%
Pharmacology, Toxicology and Pharmaceutical Science
Platinum Complex
100%
Ovary Carcinoma
100%
Triplatin Tetranitrate
100%
Cisplatin
54%
Protein P53
9%
Neoplasm
9%
Metallothionein
9%
Glutathione
9%
Cross-Resistance
9%
Cell DNA
9%
Cytotoxicity
9%
Biochemistry, Genetics and Molecular Biology
Cisplatin
100%
P53
16%
DNA Damage
16%
Upregulation
16%
Cytotoxicity
16%
Nucleophilicity
16%
Cross Resistance
16%
MLH1
16%
DNA Mismatch Repair
16%
G1/S Transition
16%
PMS2
16%
Neurofilament
16%
G2 Phase Cell Cycle Checkpoint
16%
DNA Damage Checkpoint
16%
Drug Inactivation
16%
Metallothionein
16%
Glutathione
16%
Programmed Cell Death
16%